H.B. Fuller Company (NYSE: FUL) announced that shareholders of Advanced Medical Solutions Group plc (LSE: AMS) approved the proposed acquisition at specially convened meetings held on August 12, 2026. This shareholder approval marks a significant milestone toward completing the deal, which follows the agreement on terms for a recommended cash acquisition disclosed by both companies on June 25, 2026.

The transaction is expected to close by the end of the calendar year, subject to the satisfaction or waiver of remaining conditions set forth in the transaction documents. H.B. Fuller, described as the world’s largest pureplay adhesives company, moves closer to integrating Advanced Medical Solutions into its portfolio following this regulatory and shareholder hurdle.

Strategic Rationale

Celeste Mastin, president and chief executive officer of H.B. Fuller, stated that AMS is an exceptional company and a rare strategic fit that advances the vision for the future of H.B. Fuller. By combining AMS’s leading medical technologies, innovation expertise, and regulatory capabilities with H.B. Fuller’s global scale and commercial reach, the companies aim to create a differentiated healthcare platform positioned for faster growth, stronger margins, and greater value creation.

About H.B. Fuller

As the largest pureplay adhesives company in the world, H.B. Fuller’s innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2025 revenue of $3.5 billion, the company’s mission to Connect What Matters is brought to life by more than 7,100 global team members who collaborate with customers across more than 30 market segments in 150 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets.

What the Numbers Show

The source provides no financial metrics, valuation figures, or comparative data points for this corporate action. Consequently, no analytical observation regarding revenue, margins, or balance sheet implications can be derived from the provided text.

H.B. Fuller Company (NYSE: FUL), the largest pureplay adhesives company, confirmed receipt of an unsolicited proposal from activist investor Ancora Holdings Group to acquire its Building Adhesives Solutions (BAS) business for between $1.1 billion and $1.2 billion in cash. Although Ancora previously expressed passing verbal interest in the BAS segment, this letter represents the first formal offer received by the adhesives manufacturer for the division.

Deal Dynamics

Ancora privately approached H.B. Fuller President and CEO Celeste Mastin and board chair Rasmussen on July 7, 2026, but stated it did not receive a substantive response. Consequently, the activist fund made the proposal public, outlining terms that exclude financing contingencies. Ancora indicated it is prepared to sign a confidentiality agreement and begin due diligence immediately.

H.B. Fuller’s management team and Board of Directors regularly review the company’s portfolio to maximize shareholder value creation. Consistent with that focus, the Board will carefully evaluate the proposal in consultation with its financial and legal advisors.

The shareholder argued that selling the Building Adhesive Solutions business would enable H.B. Fuller to exit a fragmented market and continue executing Project Quantum Leap. The firm added that it could raise its proposed price if the review identifies additional value in the business.

The proposal is non-binding and remains subject to confirmatory due diligence, board and any required shareholder approvals, regulatory and third-party clearances, and the negotiation of a definitive agreement. Ancora has asked H.B. Fuller’s independent directors to indicate whether the company is willing to explore a deal. It also reserved the right to modify or withdraw the proposal before a binding agreement is signed.

Market Reaction

H.B. Fuller shares fell on Wednesday following the news, closing down 1.41% at $61.16. The decline occurred during a mixed session in which the S&P 500 gained about 0.2%, while the Materials sector fell roughly 0.9%.

Technically, the stock is trading above its 20-day simple moving average (SMA) of $57.71 by about 6.1%. However, bearish signals persist with the 50-day SMA below the 200-day SMA, indicating a death cross that occurred in July. Momentum indicators reveal that the moving average convergence divergence (MACD) is above its signal line, suggesting downside pressure is easing.

Key resistance sits at $66.50, while key support is at $55.00.

Earnings Preview And Analyst Views

H.B. Fuller Company is slated to provide its next financial update on September 23, 2026 (estimated). Analysts estimate earnings per share of $1.47, up from $1.26, and revenue of $946.63 million, up from $892.04 million. The stock carries a valuation P/E of 18.4x, which analysts indicate as fair valuation.

The consensus rating remains Buy with an average price forecast of $71.25. Recent analyst actions include:

• Citigroup: Buy (Raises Target to $75.00) (June 30)
• Deutsche Bank: Buy (Raises Target to $72.00) (June 30)
• JP Morgan: Upgraded to Overweight (Raises Target to $67.00) (June 26)